Clinical and biochemical factors associated with short-term outcomes in patients with acute-on-chronic liver failure managed with an extracorporeal liver support–based protocol in Vietnam

INTRODUCTION: To describe clinical and biochemical factors associated with short-term outcomes, adverse events, and longitudinal biomarker trajectories in patients with acute-on-chronic liver failure (ACLF) managed using an extracorporeal liver support (ELS) - based protocol. METHODS: This prospective single-center observational cohort at Bach Mai Hospital included a convenience sample of 70 patients with ACLF: 35 received high-volume plasma exchange (HVP) and 35 received double plasma molecular adsorption system plus low-volume plasma exchange (DPMAS+LPE), selected by the treating team. The modalities were not randomized or designed for comparative effectiveness evaluation. Longitudinal measurements used the CRF-defined procedural labels: immediately before an ELS session (T0), immediately after removal of the DPMAS adsorption cartridges (T1), and at completion of the entire ELS session (T2). Outcomes were survival at Day 28 after hospital admission and recovery status at hospital discharge. RESULTS: Survival at Day 28 was 92.9% (65/70). Recovery at hospital discharge was successful in 37.1% (26/70). Baseline direct bilirubin was lower in the mortality group, but the mortality analysis was limited by only five deaths. Successful recovery was associated with lower neutrophil percentage, creatinine, IL-6, and severity scores and with higher platelet count, PT percentage, and bicarbonate. Descriptive modality-stratified trajectories showed decreases in total bilirubin after ELS; these trajectories should not be interpreted as a comparative treatment-effect analysis. CONCLUSION: In this small real-world cohort managed under an ELS-based protocol, recovery was associated with systemic inflammation, renal function, coagulation, and organ-failure severity. Because treatment allocation was non-randomized and only five deaths occurred, the findings are exploratory and require external validation.

Authors

Publication Details

Journal
Blood Purification
Published
2026-11-18
DOI
https://doi.org/10.1159/bpu/abpag016
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical and biochemical factors associated with short-term outcomes in patients with acute-on-chronic liver failure managed with an extracorporeal liver support–based protocol in Vietnam

Tuan Dang Quoc, Cuong Van Bui, Giang Bùi Thị Hương, Trong Nguyen Van et al.
1 links
Blood Purification
Liver Disease and Transplantation
article

Clinical and biochemical factors associated with short-term outcomes in patients with acute-on-chronic liver failure managed with an extracorporeal liver support–based protocol in Vietnam

Tuan Dang Quoc, Cuong Van Bui, Giang Bùi Thị Hương, Trong Nguyen Van, Chinh Quoc Luong, Thach Pham The, Son Ngoc Do, Toan Vuong Xuan, Tan Nguyen Cong
article en

Abstract

INTRODUCTION: To describe clinical and biochemical factors associated with short-term outcomes, adverse events, and longitudinal biomarker trajectories in patients with acute-on-chronic liver failure (ACLF) managed using an extracorporeal liver support (ELS) - based protocol. METHODS: This prospective single-center observational cohort at Bach Mai Hospital included a convenience sample of 70 patients with ACLF: 35 received high-volume plasma exchange (HVP) and 35 received double plasma molecular adsorption system plus low-volume plasma exchange (DPMAS+LPE), selected by the treating team. The modalities were not randomized or designed for comparative effectiveness evaluation. Longitudinal measurements used the CRF-defined procedural labels: immediately before an ELS session (T0), immediately after removal of the DPMAS adsorption cartridges (T1), and at completion of the entire ELS session (T2). Outcomes were survival at Day 28 after hospital admission and recovery status at hospital discharge. RESULTS: Survival at Day 28 was 92.9% (65/70). Recovery at hospital discharge was successful in 37.1% (26/70). Baseline direct bilirubin was lower in the mortality group, but the mortality analysis was limited by only five deaths. Successful recovery was associated with lower neutrophil percentage, creatinine, IL-6, and severity scores and with higher platelet count, PT percentage, and bicarbonate. Descriptive modality-stratified trajectories showed decreases in total bilirubin after ELS; these trajectories should not be interpreted as a comparative treatment-effect analysis. CONCLUSION: In this small real-world cohort managed under an ELS-based protocol, recovery was associated with systemic inflammation, renal function, coagulation, and organ-failure severity. Because treatment allocation was non-randomized and only five deaths occurred, the findings are exploratory and require external validation.

Blood Purification
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon